← back to search

Vincent A. Fischetti

Rockefeller University · US
Area of research
Public Health, Environmental and Occupational Health · Ecology
Research interest
Research interests include Microbiology, Biology, Lysin, Clostridium perfringens, Bacteria, and Biofilm.
h-index
citations
1,938
works
15
NIH funding
primary concept
email

Recent publications

Gram‐negative anaerobes elicit a robust keratinocytes immune response with potential insights into <scp>HS</scp> pathogenesis
Experimental Dermatology 2024cited by 24position: middledoi
Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
Journal of Clinical Investigation 2023cited by 47position: middledoi
PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens
Antimicrobial Agents and Chemotherapy 2023cited by 47position: middledoi
PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin Infections
Frontiers in Microbiology 2022cited by 26position: lastdoi
The global emergence of a novel Streptococcus suis clade associated with human infections
EMBO Molecular Medicine 2021cited by 94position: middledoi
Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes
Nature Microbiology 2021cited by 44position: middledoi
2020 John Charnley Award: The antimicrobial potential of bacteriophage-derived lysin in a murine debridement, antibiotics, and implant retention model of prosthetic joint infection
The Bone & Joint Journal 2020cited by 56position: middledoi
Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection
Antimicrobial Agents and Chemotherapy 2019cited by 119position: lastdoi
Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria
Antimicrobial Agents and Chemotherapy 2019cited by 119position: lastdoi
Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy
PLoS ONE 2017cited by 111position: middledoi
Alternatives to antibiotics—a pipeline portfolio review
The Lancet Infectious Diseases 2016cited by 840position: middledoi
The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin
PLoS Pathogens 2015cited by 90position: middledoi
Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope Physiology
PLoS ONE 2015cited by 23position: lastdoi
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease
PLoS ONE 2013cited by 205position: middledoi
Group A streptococcal vaccines: Paving a path for accelerated development
Vaccine 2013cited by 93position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chad W. Euler · Cornell University5 papers (2019–2023)Anna Serrano‐Mollar · Rockefeller University3 papers (2015–2023)Assaf Raz · Rockefeller University3 papers (2015–2023)Ryan D. Heselpoth · University of Maryland, College Park2 papers (2019–2022)Anaise Hernandez · Rockefeller University2 papers (2019–2023)Kareem Rashid Rumah · Rockefeller University2 papers (2013–2015)Timothy Vartanian · Cornell University2 papers (2013–2015)Jinquan Li · South China Agricultural University2 papers (2021–2023)Jennifer R. Linden · Cornell University2 papers (2013–2015)Ian R. Henderson · University of Birmingham1 papers (2016–2016)Andrew Varble · University of Rochester Medical Center1 papers (2021–2021) · 1 papers (2016–2016) · 1 papers (2015–2015)Raymond Schuch · Rockefeller University1 papers (2019–2019)John Rex · The University of Texas at Austin1 papers (2016–2016)Hong Hur · Rockefeller University1 papers (2024–2024) · 1 papers (2013–2013)Martha R. J. Clokie · University of Leicester1 papers (2016–2016)Gilad Bachrach · Hebrew University of Jerusalem1 papers (2015–2015)Edmondo Campisi · Rockefeller University1 papers (2021–2021)